FDA approves groundbreaking Alzheimer's drug.
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D002800:Cholinesterase Inhibitors / Q000145:classification / Q000627:therapeutic use; D017277:Drug Approval; D018691:Excitatory Amino Acid Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D008559:Memantine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D002800:Cholinesterase Inhibitors; D018691:Excitatory Amino Acid Antagonists; D008559:Memantine